Animal research points to a new use for incretin drugs A recent laboratory study in the U.K. found that GLP‑1 receptor agonists — the class of drugs commonly used for diabetes and weight loss — can reduce a dangerous complication that sometimes follows treatment for a heart attack. Researchers…
Continue reading...
Continue reading...